Furthermore, it was demonstrated that TET2, IDH1, and IDH2 gene mutations were driver mutations (that probably have a role in the pathogenesis of the disorder) and are acquired with the evolution of MDS to AML. This evidence concerns the gene TET2 and acute myeloid leukemia.